Zura Bio (ZURA) Total Non-Current Liabilities (2021 - 2024)

Zura Bio's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $18.2 million for Q3 2024.

• On a quarterly basis, Total Non-Current Liabilities rose 7.24% year-over-year to $18.2 million in Q3 2024; TTM through Sep 2024 was $18.2 million, a 7.24% increase from a year earlier, with the FY2023 full-year figure at $20.3 million, up 358.49% from the prior year.
• Total Non-Current Liabilities climbed to $18.2 million in Q3 2024 per ZURA's latest filing, from $15.1 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $20.3 million in Q4 2023 and bottomed at $4.3 million in Q4 2021.
• The 4-year median for Total Non-Current Liabilities is $14.7 million (2024), against an average of $11.7 million.
• Across the five-year window, Total Non-Current Liabilities surged 358.49% in 2023 and retreated 24.41% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $4.3 million in 2021, then advanced by 3.4% to $4.4 million in 2022, then jumped by 358.49% to $20.3 million in 2023, then decreased by 10.14% to $18.2 million in 2024.
• Per Business Quant, the three latest ZURA Total Non-Current Liabilities figures stand at $18.2 million (Q3 2024), $15.1 million (Q2 2024), and $14.7 million (Q1 2024).